NCT06875583

Brief Summary

Doctors and nurses who perform heart procedures using X-ray guidance are exposed to radiation, which can be harmful over time. This exposure increases the risk of certain health problems, including cancers, eye damage (cataracts), and DNA damage. Although protective lead clothing is used to reduce exposure, it is heavy, uncomfortable, and can cause muscle and joint problems for those who wear it daily. A new radiation protection device, called RAMPART, may help reduce radiation exposure for heart specialists and their teams. It could also allow them to wear lighter protective gear-or none at all-making their work safer and more comfortable. This study will compare the radiation levels received by doctors and nurses during heart procedures when using RAMPART versus standard protection. By doing so, we hope to find out if this new device can better protect medical teams from radiation, improving both their safety and well-being.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 17, 2025

Completed
24 days until next milestone

First Posted

Study publicly available on registry

March 13, 2025

Completed
6 months until next milestone

Study Start

First participant enrolled

August 29, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

November 24, 2025

Status Verified

August 1, 2025

Enrollment Period

6 months

First QC Date

February 17, 2025

Last Update Submit

November 19, 2025

Conditions

Keywords

radiation exposureradiation exposure to operatorradiation injuriesradiation safety

Outcome Measures

Primary Outcomes (1)

  • 1st Operator Eye radiation

    To assess the effect of using a new medical device (RAMPART) in reducing the amount of radiation the first operator is exposed to (at eye level) when performing coronary angiography or angioplasty. Measurement of radiation in µSv.

    1) Periprocedural 2) Cumulative dose - through study completion, an average of 1 year

Secondary Outcomes (3)

  • 1st Operator Chest / Groind radiation

    1) Periprocedural 2) Cumulative dose - through study completion, an average of 1 year

  • 2nd Operator Radiation - all levels

    1) Periprocedural 2) Cumulative dose - through study completion, an average of 1 year

  • 'Circulating Nurse' Radiation

    1) Periprocedural 2) Cumulative dose - through study completion, an average of 1 year

Study Arms (2)

RAMPART Arm

EXPERIMENTAL

The use of the RAMPART system to reduce operator radiation exposure

Device: Radiation

Standard Arm

NO INTERVENTION

Standard radiation protection

Interventions

RadiationDEVICE

The use of RAMPART radiation protection device

Also known as: Use of RAMPART radiation protection device
RAMPART Arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All procedures involving adult patients (\>18 year of age)
  • Male or female patients
  • Planned to undergo either an elective or urgent coronary intervention procedure involving ionising radiation in the cardiac catheter lab, via the right and or left radial arteries.

You may not qualify if:

  • Procedures involving patients less than 18 years of age
  • Patients unable to give valid consent
  • Pregnancy
  • Femoral approach procedure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Liverpool Heart & Chest Hospital

Liverpool, L14 3PE, United Kingdom

RECRUITING

Related Publications (2)

  • Lisko JC, Shekiladze N, Chamoun J, Sheikh N, Rainer K, Wei J, Binongo J, Raj L, Byku I, Rinfret S, Devireddy C, Jaber WA, Greenbaum AB, Babaliaros V, Steuterman S, Sandesara P, Nicholson WJ. Radiation Exposure Using Rampart vs Standard Lead Aprons and Shields During Invasive Cardiovascular Procedures. J Soc Cardiovasc Angiogr Interv. 2023 Oct 19;3(1):101184. doi: 10.1016/j.jscai.2023.101184. eCollection 2024 Jan.

  • Noor HA, Althawadi N, Noor Z, AlAnsari N, Chachar TS, Al Raisi S, Yousif N. Radiation Exposure During Invasive Cardiovascular Procedures: Portable Shielding System Versus Standard Lead Aprons. Cureus. 2024 Aug 29;16(8):e68108. doi: 10.7759/cureus.68108. eCollection 2024 Aug.

MeSH Terms

Conditions

Radiation Injuries

Interventions

Radiotherapy

Condition Hierarchy (Ancestors)

Wounds and Injuries

Intervention Hierarchy (Ancestors)

Therapeutics

Central Study Contacts

John D Hung, MBChB PhD MRCP(UK)

CONTACT

Debar Rasoul, MBChB BSc MRCP(UK)

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Multi-centre randomised controlled trial. Coronary catheter laboratory procedures will be randomised 1:1 to RAMPART vs standard radiation protection using a pre-defined randomisation schedule.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant Cardiologist, Chief Investigator

Study Record Dates

First Submitted

February 17, 2025

First Posted

March 13, 2025

Study Start

August 29, 2025

Primary Completion

March 1, 2026

Study Completion

March 1, 2026

Last Updated

November 24, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will share

Direct access will be granted to the Sponsor, host institution and the regulatory authorities to permit trial-related monitoring, audits and inspections in line with participant consent. Furthermore, all data will be shared through publication and via online additional data supplements.

Shared Documents
STUDY PROTOCOL, CSR
Time Frame
End of trial and publication
Access Criteria
1. Published Journal platform 2. Open Source Framework - https://osf.io/
More information

Locations